Scalisi, Joshua ; Université de Liège - ULiège > GIGA > GIGA Neurosciences - Nervous system disorders and therapy
COKAIKO, Julie ; Centre Hospitalier Universitaire de Liège - CHU
Wantz, May; Luxembourg Institute of Health > Immuno-Pharmacology and Interactomics
Szpakowska, Martyna; Luxembourg Institute of Health > Immuno-Pharmacology and Interactomics
Chevigné, Andy; Luxembourg Institute of Health > Immuno-Pharmacology and Interactomics
Rogister, Bernard ; Université de Liège - ULiège > GIGA > GIGA Neurosciences - Nervous system disorders and therapy ; Centre Hospitalier Universitaire de Liège - CHU > > Service de neurologie
D.N. Louis et al. The 2021 WHO classification of tumors of the Central Nervous System: A summary Neuro Oncol. 2021 23 1231 1251 1:CAS:528:DC%2BB3MXisFSht73J 34185076 8328013 10.1093/neuonc/noab106
Q.T. Ostrom et al. CBTRUS Statistical Report: Primary brain and other Central Nervous System tumors diagnosed in the United States in 2016–2020 Neuro Oncol. 2023 25 IV1 IV99 37793125 10.1093/neuonc/noad149
R. Stupp et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N. Engl. J. Med. 2005 352 987 996 1:CAS:528:DC%2BD2MXit1Wksbk%3D 15758009 10.1056/NEJMoa043330
P.Y. Wen S. Kesari Malignant gliomas in adults N Engl. J. Med. 2008 359 492 507 1:CAS:528:DC%2BD1cXpt1Sgsrw%3D 18669428 10.1056/NEJMra0708126
C. Neftel et al. An integrative model of cellular states, plasticity, and genetics for glioblastoma Cell 2019 178 835 849e21 1:CAS:528:DC%2BC1MXhsVWlur7I 31327527 6703186 10.1016/j.cell.2019.06.024
Dirkse, A. et al. Stem cell-associated heterogeneity in glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment. Nat. Commun.10 (2019).
Y.A. Yabo S.P. Niclou A. Golebiewska Cancer cell heterogeneity and plasticity: A paradigm shift in glioblastoma Neuro Oncol. 2021 10.1093/NEUONC/NOAB269 9071273
Zlotnik, A. & Yoshie, O. Chemokine Superfamily Revisit. Immun. 36, 705 (2012).
A. Zlotnik Chemokines and cancer Int. J. Cancer 2006 119 2026 2029 1:CAS:528:DC%2BD28XhtVSks7bE 16671092 10.1002/ijc.22024
V.M. Poeta M. Massara A. Capucetti R. Bonecchi Chemokines and chemokine receptors: New targets for cancer immunotherapy Front. Immunol. 2019 10 379 1:CAS:528:DC%2BC1MXhsVSgtL3L 10.3389/fimmu.2019.00379
D. Isci et al. Patient-oriented perspective on chemokine receptor expression and function in Glioma Cancers (Basel) 2022 14 130 1:CAS:528:DC%2BB38Xms1Snu7s%3D 10.3390/cancers14010130
N. Goffart et al. Adult mouse subventricular zones stimulate glioblastoma stem cells specific invasion through CXCL12/CXCR4 signaling Neuro Oncol. 2015 17 81 94 1:CAS:528:DC%2BC28XitFSisrzE 25085362 10.1093/neuonc/nou144
J. Kroonen et al. Human glioblastoma-initiating cells invade specifically the subventricular zones and olfactory bulbs of mice after striatal injection Int. J. Cancer 2011 129 574 585 1:CAS:528:DC%2BC3MXmsFGisbg%3D 20886597 10.1002/ijc.25709
K. Balabanian et al. The chemokine SDF-1/CXCL12 binds to and signals through the Orphan receptor RDC1 in T lymphocytes J. Biol. Chem. 2005 280 35760 35766 1:CAS:528:DC%2BD2MXhtFWmurjO 16107333 10.1074/jbc.M508234200
Y.C. Yen et al. Structures of atypical chemokine receptor 3 reveal the basis for its promiscuity and signaling bias Sci. Adv. 2022 8 8063 10.1126/sciadv.abn8063
Shimizu, S., Brown, M., Sengupta, R., Penfold, M. E. & Meucci, O. CXCR7 protein expression in human adult brain and differentiated neurons. PLoS ONE6 (2011).
H. Gerrits et al. Early postnatal lethality and cardiovascular defects in CXCR7-deficient mice Genesis 2008 46 235 245 1:CAS:528:DC%2BD1cXotFGgtr8%3D 18442043 10.1002/dvg.20387
F. Sierro et al. Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7 Proc. Natl. Acad. Sci. 2007 104 14759 14764 2007PNAS.10414759S 1:CAS:528:DC%2BD2sXhtVOns7nO 17804806 1976222 10.1073/pnas.0702229104
Y. Wang et al. CXCR4 and CXCR7 have distinct functions in regulating Interneuron Migration Neuron 2011 69 61 1:CAS:528:DC%2BC3MXktFSjtg%3D%3D 21220099 3025760 10.1016/j.neuron.2010.12.005
Fumagalli, A. et al. The atypical chemokine receptor 3 interacts with Connexin 43 inhibiting astrocytic gap junctional intercellular communication. Nat. Commun.11 (2020).
J. Koenen F. Bachelerie K. Balabanian G. Schlecht-Louf C. Gallego Atypical chemokine receptor 3 (ACKR3): A comprehensive overview of its expression and potential roles in the immune system Mol. Pharmacol. 2019 96 809 818 1:CAS:528:DC%2BB3cXis1Crtrk%3D 31040166 10.1124/mol.118.115329
M. Neves et al. The role of ACKR3 in breast, lung, and brain cancer Mol. Pharmacol. 2019 96 819 825 1:CAS:528:DC%2BB3cXis1Crtrc%3D 30745320 10.1124/mol.118.115279
K. Hattermann et al. Effects of the chemokine CXCL12 and combined internalization of its receptors CXCR4 and CXCR7 in human MCF-7 breast cancer cells Cell. Tissue Res. 2014 357 253 266 2014opgl.book...H 1:CAS:528:DC%2BC2cXntFOksb0%3D 24770893 4077318 10.1007/s00441-014-1823-y
K. Hattermann et al. The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects Cancer Res. 2010 70 3299 3308 1:CAS:528:DC%2BC3cXkslShurc%3D 20388803 10.1158/0008-5472.CAN-09-3642
A. Levoye K. Balabanian F. Baleux F. Bachelerie B. Lagane CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling Blood 2009 113 6085 6093 1:CAS:528:DC%2BD1MXnslSmurk%3D 19380869 10.1182/blood-2008-12-196618
R.D. Berahovich et al. Endothelial expression of CXCR7 and the regulation of systemic CXCL12 levels Immunology 2014 141 111 1:CAS:528:DC%2BC3sXhvV2iurnJ 24116850 10.1111/imm.12176
U. Naumann et al. CXCR7 functions as a scavenger for CXCL12 and CXCL11 PLoS One 2010 5 e9175 2010PLoSO..5.9175N 20161793 2820091 10.1371/journal.pone.0009175
T.L. Gonçalves L.P. de Araújo Pereira Ferrer, V. Tamoxifen as a modulator of CXCL12-CXCR4-CXCR7 chemokine axis: A breast cancer and glioblastoma view Cytokine 2023 170 156344 37639844 10.1016/j.cyto.2023.156344
Ehrlich, A. T. et al. Ackr3-Venus knock-in mouse lights up brain vasculature. Mol. Brain14 (2021).
N. Goffart et al. CXCL12 mediates glioblastoma resistance to radiotherapy in the subventricular zone Neuro Oncol. 2017 19 66 77 1:CAS:528:DC%2BC1cXitFSntr7L 27370398 10.1093/neuonc/now136
N. Goffart et al. Adult mouse subventricular zones stimulate glioblastoma stem cells specific invasion through CXCL12/CXCR4 signaling Neuro Oncol. 2015 10.1093/neuonc/nou144 25085362
M. Cebo et al. Platelet ACKR3/CXCR7 favors antiplatelet lipids over an atherothrombotic lipidome and regulates thromboinflammation Blood 2022 139 1722 1742 1:CAS:528:DC%2BB38XnsFGhtr4%3D 34905596 10.1182/blood.2021013097
Del Barrio, I. M., Wilkins, G. C., Meeson, A., Ali, S. Kirby, J. A. Breast Cancer: An examination of the potential of ACKR3 to modify the response of CXCR4 to CXCL12. Int. J. Mol. Sci. 19 (2018).
B. Song et al. Stromal cell-derived factor-1 exerts opposing roles through CXCR4 and CXCR7 in angiotensin II-induced adventitial remodeling Biochem. Biophys. Res. Commun. 2022 594 38 45 1:CAS:528:DC%2BB38Xhs1Cqurw%3D 35066378 10.1016/j.bbrc.2022.01.030
M.J. Walters et al. Inhibition of CXCR7 extends survival following irradiation of brain tumours in mice and rats Br. J. Cancer 2014 110 1179 1188 1:CAS:528:DC%2BC2cXhtVyhsr0%3D 24423923 3950859 10.1038/bjc.2013.830
M.J. Smit et al. The CXCL12/CXCR4/ACKR3 Axis in the Tumor Microenvironment: Signaling, crosstalk, and therapeutic targeting Annu. Rev. Pharmacol. Toxicol. 2021 61 541 563 1:CAS:528:DC%2BB3cXhvVOmur3P 32956018 10.1146/annurev-pharmtox-010919-023340
A. Bayrak et al. Discovery and Development of First-in-class ACKR3/CXCR7 superagonists for platelet degranulation modulation J. Med. Chem. 2022 65 13365 13384 1:CAS:528:DC%2BB38XisVGqsrbK 36150079 10.1021/acs.jmedchem.2c01198
Szpakowska, M. et al. The natural analgesic conolidine targets the newly identified opioid scavenger ACKR3/CXCR7. Signal. Transduct. Target. Ther. 6 (2021).
Meyrath, M. et al. The atypical chemokine receptor ACKR3/CXCR7 is a broad-spectrum scavenger for opioid peptides. Nat. Commun.11 (2020).
E. Sjöberg et al. The diverse and complex roles of atypical chemokine receptors in cancer: From molecular biology to clinical relevance and therapy Adv. Cancer Res. 2020 145 99 138 32089166 10.1016/bs.acr.2019.12.001
A.M. Bianco et al. CXCR7 and CXCR4 expressions in Infiltrative Astrocytomas and their interactions with HIF1α expression and IDH1 mutation Pathol. Oncol. Res. 2015 21 229 240 1:CAS:528:DC%2BC2cXhtV2jtrrE 24970694 10.1007/s12253-014-9813-7
C. Calatozzolo et al. Expression of the new CXCL12 receptor, CXCR7, in gliomas Cancer Biol. Ther. 2011 11 242 253 1:CAS:528:DC%2BC3MXislyhurk%3D 21084856 10.4161/cbt.11.2.13951
M. Esencay Y. Sarfraz D. Zagzag CXCR7 is induced by hypoxia and mediates glioma cell migration towards SDF-1α BMC Cancer 2013 10.1186/1471-2407-13-347 23865743 3728118
R.D. Berahovich M.E.T. Penfold T.J. Schall Nonspecific CXCR7 antibodies Immunol. Lett. 2010 133 112 114 1:CAS:528:DC%2BC3cXht1Wju7nJ 20691730 10.1016/j.imlet.2010.06.010
Neves, M. et al. Special section: From insight to modulation of CXCR4 and ACKR3 (CXCR7) function-minireview the role of ACKR3 in breast, lung, and brain cancer. https://doi.org/10.1124/mol.118.115279
M. Samus A. Rot Atypical chemokine receptors in cancer Cytokine 2024 176 156504 1:CAS:528:DC%2BB2cXhvFCitrw%3D 38266462 10.1016/j.cyto.2024.156504
Giordano, F. A. et al. L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: Dose escalation of the phase I/II GLORIA trial. Nat. Commun. 15 (1), 1–14 (2024).
M. Puchert et al. Astrocytic expression of the CXCL12 receptor, CXCR7/ACKR3 is a hallmark of the diseased, but not developing CNS Mol. Cell. Neurosci. 2017 85 105 118 1:CAS:528:DC%2BC2sXhsFKjurbE 28889992 10.1016/j.mcn.2017.09.001
M.J. Walters et al. Inhibition of CXCR7 extends survival following irradiation of brain tumours in mice and rats Br. J. Cancer 2014 10.1038/bjc.2013.830 24423923 3950859
P. Birner A. Tchorbanov S. Natchev J. Tuettenberg M. Guentchev The chemokine receptor CXCR7 influences prognosis in human glioma in an IDH1-dependent manner J. Clin. Pathol. 2015 68 830 834 1:CAS:528:DC%2BC28XhtVChsrnJ 26109200 10.1136/jclinpath-2015-202886
N. Salazar et al. A chimeric antibody against ACKR3/CXCR7 in combination with TMZ activates Immune responses and extends survival in mouse GBM models Mol. Ther. 2018 26 1354 1365 1:CAS:528:DC%2BC1cXovVagt7o%3D 29606504 5993942 10.1016/j.ymthe.2018.02.030
P. Antonello et al. ACKR3 promotes CXCL12/CXCR4-mediated cell-to-cell-induced lymphoma migration through LTB4 production Front. Immunol. 2023 13 1067885 36713377 9878562 10.3389/fimmu.2022.1067885
M. Szpakowska et al. Human herpesvirus 8-encoded chemokine vCCL2/vMIP-II is an agonist of the atypical chemokine receptor ACKR3/CXCR7 Biochem. Pharmacol. 2016 114 14 21 1:CAS:528:DC%2BC28Xoslamtr8%3D 27238288 10.1016/j.bcp.2016.05.012
Neves, M., Marolda, V., Mayor, F. & Penela, P. Crosstalk between CXCR4/ACKR3 and EGFR signaling in breast Cancer cells. Int. J. Mol. Sci.23 (2022).
V. Puddinu et al. ACKR3 expression on diffuse large B cell lymphoma is required for tumor spreading and tissue infiltration Oncotarget 2017 8 85068 85084 29156704 5689594 10.18632/oncotarget.18844